Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.
The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter
| November Rank | October Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
|---|---|---|---|---|---|
| 1 | 1 | Pfizer | 5,104 | 2 | 46 |
| 2 | 14 | Lilly | 2,471 | 0 | 19 |
| 3 | 2 | Moderna | 2,132 | 0 | 0 |
| 4 | 3 | Johnson & Johnson | 1,261 | 2 | 43 |
| 5 | 4 | AstraZeneca | 752 | 2 | 44 |
| 6 | 5 | GSK | 651 | 2 | 73 |
| 7 | 7 | Roche | 380 | 0 | 33 |
| 8 | 10 | Novo Nordisk | 342 | 0 | 19 |
| 9 | 20 | AbbVie | 339 | 5 | 3 |
| 10 | 12 | Sanofi | 328 | 1 | 31 |
| 11 | 9 | Novartis | 291 | 2 | 18 |
| 12 | 16 | Takeda | 284 | 2 | 4 |
| 13 | 11 | Bayer | 274 | 0 | 40 |
| 14 | 6 | Abbott | 229 | 0 | 6 |
| 15 | 17 | Boehringer Ingelheim | 192 | 0 | 8 |
| 16 | 8 | Merck & Co | 189 | 6 | 17 |
| 17 | 19 | Eisai | 172 | 0 | 6 |
| 18 | 21 | Biogen | 127 | 0 | 1 |
| 19 | 15 | Amgen | 108 | 2 | 19 |
| 20 | 13 | Gilead Sciences | 106 | 74 | 0 |
| 21 | 18 | Fresenius | 82 | 0 | 6 |
| 22 | 23 | Otsuka | 78 | 0 | 1 |
| 23 | 22 | BMS | 77 | 5 | 0 |
| 24 | 29 | Organon | 70 | 0 | 0 |
| 25 | 32 | Merck KGaA | 62 | 0 | 20 |
| 26 | 26 | Servier | 58 | 0 | 8 |
| 27 | 31 | Ipsen | 57 | 0 | 3 |
| 28 | 42 | Vertex | 53 | 0 | 0 |
| 29 | 25 | Teva | 52 | 0 | 23 |
| 30 | 30 | Daiichi Sankyo | 52 | 0 | 1 |
| 31 | 35 | Viatris | 52 | 0 | 0 |
| 32 | 38 | Astellas | 48 | 0 | 0 |
| 33 | 24 | Stada | 38 | 0 | 0 |
| 34 | 34 | CSL | 36 | 0 | 1 |
| 35 | 27 | Regeneron | 30 | 0 | 1 |
| 36 | 28 | UCB | 29 | 0 | 10 |
| 37 | 36 | Menarini | 27 | 0 | 3 |
| 38 | 33 | Bausch | 23 | 0 | 0 |
| 39 | 39 | Alexion | 21 | 0 | 1 |
| 40 | 37 | Grifols | 18 | 0 | 0 |
| 41 | 45 | Kyowa Kirin | 9 | 0 | 0 |
| 42 | 41 | Jazz Pharmaceuticals | 6 | 0 | 0 |
| 42 | 40 | Aurobindo | 6 | 0 | 0 |
| 44 | 42 | CSPC | 5 | 0 | 0 |
| 45 | 44 | Sun | 4 | 0 | 0 |
| 50 | 50 | Jiangsu Hengrui | 0 | 0 | 0 |
| 50 | 50 | Endo | 0 | 0 | 0 |
| 50 | 50 | Sino | 0 | 0 | 0 |
| 50 | 50 | Shanghai | 0 | 0 | 0 |
| 50 | 50 | Sumitomo Dainippon | 0 | 0 | 0 |
The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies
The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter in November 2022 were Pfizer, Lilly, Moderna, Johnson & Johnson and AstraZeneca. Notably, Lilly rose from the 14th most mentioned pharmaceutical company online in October 2022 to 2nd in November.
CREATION.co identified 14,537 HCP mentions of pharmaceutical companies online in November 2022, a 22% decrease from the previous month.
The primary factor of Lilly’s rise in ranking of most mentioned pharmaceutical companies in November 2022 was discussions around the cost of insulin, with HCPs expressing frustration and anger at the increase of the price of insulin since its discovery, with 387 HCPs sharing a tweet by Bernie Sanders expressing that sentiment.
Let's be clear. Eli Lilly should apologize for increasing the price of insulin by over 1,200% since 1996 to $275 while it costs less than $10 to manufacture. The inventors of insulin sold their patents in 1923 for $1 to save lives, not to make Eli Lilly's CEO obscenely rich. https://t.co/5ZpZkqY0f9
— Bernie Sanders (@BernieSanders) November 11, 2022
218 HCPs also shared a tweet highlighting the financial consequences of a Twitter Blue post in which Eli Lilly’s official account was impersonated:
Huge news for the babies!
Pfizer’s bivalent RSV vaccine has demonstrated amazing efficacy (81.8% against severe lower respiratory illness). This was well tolerated and with results meeting criteria, Pfizer has stopped enrollment and will plan to submit by end of 2022! pic.twitter.com/dObCKEjBJT
— Dr. Neuro 🏳️🌈 🦠💉💪 (@Neurofourier) November 1, 2022
The top shared links by HCPs discussed:
- An article from Stat news about the new bivalent COVID-19 vaccine and its efficacy in protecting against new Omicron variants.
- A press release by Pfizer announcing phase 3 trial data for their bivalent RSV vaccine.
- An article by the Washington Post about the fake tweet imitating Eli Lilly.
HCPs also shared their excitement about the efficacy of Pfizer’s new bivalent RSV vaccine, with 82 HCPs sharing the following tweet:
Huge news for the babies!
Pfizer’s bivalent RSV vaccine has demonstrated amazing efficacy (81.8% against severe lower respiratory illness). This was well tolerated and with results meeting criteria, Pfizer has stopped enrollment and will plan to submit by end of 2022! pic.twitter.com/dObCKEjBJT
— Dr. Neuro 🏳️🌈 🦠💉💪 (@Neurofourier) November 1, 2022
Additionally, Gilead Sciences had a high number of account mentions, with 74 mentions of their official Twitter account. This was primarily due to work with the Gilead scholarships:
Es un honor compartido con la Dra. @AnaisCorma, co-IP del proyecto, y con el resto del Grupo @EVirologia Muchas gracias a @GileadSciences por su apoyo a la investigación biomédica en España. https://t.co/OKc2naaRhd
— Juan A. Pineda (@japineda_) November 27, 2022
Emocionante entrega de Becas de investigación @GileadSciences @SaludISCIII Lideramos con @xdopazo un proyecto de cribado de HepC basado en inteligencia artificial en base poblacional de Salud @saludand Algoritmos que cambiarán el futuro @HospitalUVRocio @ibis_sevilla @IAVANTE_FPS pic.twitter.com/Xyo2qm1Apx
— Manuel Romero-Gómez (@mromerogomez) November 23, 2022
CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.
To stay up to date, you can sign up to CREATION.co’s monthly eJournal.
Methodology notes:
-
- In November 2022, CREATION Pinpoint® identified 14,537 healthcare professional authored tweets from 6,384 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue).
- Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 November and 30 November 2022.
- Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
- In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In November 2022, 110 of these posts mentioned Janssen.
